ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...-of-EGFR-mutation-in-squamous-cell-carcinoma

Date: 27 Sep 2014
Presenter: Silvia Novello
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/A-ROS1-translocated-NSCLC-patient

Date: 27 Sep 2014
Presenter: Ken O'Byrne
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic, Pathology/Molecular Biology, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-metastatic-non-small-cell-lung-cancer-NSCLC

AimIncreased expression of excision repair cross-complementing group 1 (ERCC1) protein might be associated with platinum resistance in NSCLC, based on retrospective and meta-analyses findings.

Date: 27 Sep 2014
Presenter: Siow-Ming Lee
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ng-cancer-NSCLC-treated-with-EGFR-TKIs-E-TKI

AimSubset analyses from 9 randomized trials report conflicting results concerning the ability of KRAS mutation (M+) status to predict benefit from E-TKIs. This pooled analysis of 4 trials of E-TKIs v...

Date: 27 Sep 2014
Presenter: Alona Zer
Resources: Abstract
Topics: Non-Small-Cell Lung Cancer, Metastatic, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ted-NSCLC-patients-What-is-the-best-approach

Date: 27 Sep 2014
Presenter: Benjamin Besse
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic

http://oncologypro.esmo.org/Meeting-Resourc...ion-biomarkers-Who-should-be-tested-and-when

Date: 27 Sep 2014
Presenter: Pasi Janne
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic, Personalised Medicine

http://oncologypro.esmo.org/Meeting-Resourc...we-define-progression-and-what-is-to-be-done

Date: 27 Sep 2014
Presenter: Anne-Marie Dingemans
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic

http://oncologypro.esmo.org/Meeting-Resourc...tration-for-targeted-agents-and-chemotherapy

Date: 27 Sep 2014
Presenter: Tony Mok
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic

http://oncologypro.esmo.org/Meeting-Resourc...2014/Is-there-anything-new-in-squamous-cells

Date: 27 Sep 2014
Presenter: Wilfried Eberhardt
Resources: Presentation, Webcast
Topic: Non-Small-Cell Lung Cancer, Metastatic

http://oncologypro.esmo.org/Meeting-Resourc...EGFR-mutations-a-randomised-controlled-trial

AimThe results of fastact2 show that chemotherapy plus erlotinib significantly prolonged PFS and OS of patients with NSCLC. However, outcome of the combination therapy are similar to those reported in...

Date: 27 Sep 2014
Presenter: Bo Jin
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Non-Small-Cell Lung Cancer, Metastatic, Personalised Medicine